Sex-Specific Differences in Management and Outcomes of Cardiogenic Shock Patients With and Without Ischemic

Ik Hyun Park1, Chang Hoon Kim2, Woo Jin Jang3

  • 1Department of Cardiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.

PubMed

Insights

Sex does not significantly impact cardiogenic shock (CS) management or mortality, regardless of whether ischemic cardiomyopathy (ICMP) is present. This study found comparable outcomes for both male and female patients with CS.

Area of Science:

  • Cardiology
  • Clinical Research
  • Sex-Based Medicine

Background:

  • Limited data exists on sex-based differences in cardiogenic shock (CS) management and outcomes.
  • Investigating these differences is crucial for personalized patient care.
  • Stratification by underlying etiology, such as ischemic cardiomyopathy (ICMP), is necessary.

Purpose of the Study:

  • To determine if clinical management and outcomes in patients with CS differ between sexes.
  • To analyze these differences stratified by CS etiology (ICMP vs. non-ICMP).

Main Methods:

  • Analysis of 1,247 CS patients from the multicenter RESCUE registry.
  • Stratification by sex and CS etiology (ICMP and non-ICMP).
  • Utilized multivariable Cox proportional hazards models and propensity-score matching for analysis.

Main Results:

  • Among ICMP patients, females underwent coronary angiography less frequently, but revascularization success rates were similar.
  • In-hospital 30-day mortality was comparable between sexes in both ICMP and non-ICMP groups.
  • 12-month mortality risk also remained similar between sexes across both etiological groups.

Conclusions:

  • No significant sex-based differences were observed in the management of CS.
  • In-hospital and 12-month mortality rates were comparable between females and males with CS.
  • These findings hold true irrespective of the underlying etiology of CS.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
65
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
49
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
20
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
44